Trial intelligence / Profile preview

Flexible GnRH Antagonist vs Flare up GnRH Agonist in Poor Responders

NCT00417066Phase 4Completed

Sponsor
Eugonia
Start
Sep 2003
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ganirelix in infertility, primary ovarian insufficiency (POI), sponsored by Eugonia. Started Sep 2003; status: completed.

02

Drugs

ganirelix
03

Conditions

infertilityprimary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT00417066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00417066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call